SAR231893 (REGN668)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR231893 (REGN668), covering 2013-12-06 to 2013-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects [Phase 1]